Evidence map›Paper›PMID 35043638›Full record

ArticleAnalytical chemistry2022

SARS-CoV-2 Aptasensors Based on Electrochemical Impedance Spectroscopy and Low-Cost Gold Electrode Substrates.

Perrine Lasserre, Banushan Balansethupathy, Vincent J Vezza, Adrian Butterworth, Alexander Macdonald, Ewen O Blair, Liam McAteer, Stuart Hannah, Andrew C Ward, Paul A Hoskisson and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Analytical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Aptamers 101: aptamer discovery andChemical science · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Electrochemical analysis based on bioaffinity.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Perrine LasserreDepartment of Biomedical Engineering, University of Strathclyde, 106 Rottenrow East, Glasgow G4 0NW, U.K.ORCID 0000-0001-8927-5649
Banushan BalansethupathyAptamer Group, Suite 2.78-2.91, Bio Centre, Innovation Way, Heslington, York YO10 5NY, U.K.
Vincent J VezzaDepartment of Biomedical Engineering, University of Strathclyde, 106 Rottenrow East, Glasgow G4 0NW, U.K.ORCID 0000-0002-4124-2773
Adrian ButterworthDepartment of Biomedical Engineering, University of Strathclyde, 106 Rottenrow East, Glasgow G4 0NW, U.K.ORCID 0000-0002-0463-927X
Alexander MacdonaldDepartment of Biomedical Engineering, University of Strathclyde, 106 Rottenrow East, Glasgow G4 0NW, U.K.
Ewen O BlairDepartment of Biomedical Engineering, University of Strathclyde, 106 Rottenrow East, Glasgow G4 0NW, U.K.
Liam McAteerDepartment of Biomedical Engineering, University of Strathclyde, 106 Rottenrow East, Glasgow G4 0NW, U.K.
Stuart HannahDepartment of Biomedical Engineering, University of Strathclyde, 106 Rottenrow East, Glasgow G4 0NW, U.K.
Andrew C WardDepartment of Civil and Environmental Engineering, University of Strathclyde, 75 Montrose Street, Glasgow G1 1XJ, U.K.
Paul A HoskissonStrathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, U.K.ORCID 0000-0003-4332-1640
Alistair LongmuirLifeScan Scotland Ltd, Beechwood Park North, Inverness IV2 3ED, U.K.
Steven SetfordLifeScan Scotland Ltd, Beechwood Park North, Inverness IV2 3ED, U.K.
Eoghan C W FarmerNHS GGC, Department of Microbiology, Glasgow Royal Infirmary, NEW Lister Building, Glasgow G31 2ER, United Kingdom.
Michael E MurphyNHS GGC, Department of Microbiology, Glasgow Royal Infirmary, NEW Lister Building, Glasgow G31 2ER, United Kingdom.
Harriet FlynnAptamer Group, Suite 2.78-2.91, Bio Centre, Innovation Way, Heslington, York YO10 5NY, U.K.
Damion K CorriganDepartment of Biomedical Engineering, University of Strathclyde, 106 Rottenrow East, Glasgow G4 0NW, U.K.
University of Strathclyde · GBNHS Greater Glasgow and Clyde · GBNovaBiotics (United Kingdom) · GBUniversity of York · GB

Funding

Chief Scientist Office COV/SCL/20/04
6 · The paper itself

Abstract

SARS-CoV-2 diagnostic practices broadly involve either quantitative polymerase chain reaction (qPCR)-based nucleic amplification of viral sequences or antigen-based tests such as lateral flow assays (LFAs). Reverse transcriptase-qPCR can detect viral RNA and is the gold standard for sensitivity. However, the technique is time-consuming and requires expensive laboratory infrastructure and trained staff. LFAs are lower in cost and near real time, and because they are antigen-based, they have the potential to provide a more accurate indication of a disease state. However, LFAs are reported to have low real-world sensitivity and in most cases are only qualitative. Here, an antigen-based electrochemical aptamer sensor is presented, which has the potential to address some of these shortfalls. An aptamer, raised to the SARS-CoV-2 spike protein, was immobilized on a low-cost gold-coated polyester substrate adapted from the blood glucose testing industry. Clinically relevant detection levels for SARS-CoV-2 are achieved in a simple, label-free measurement format using sample incubation times as short as 15 min on nasopharyngeal swab samples. This assay can readily be optimized for mass manufacture and is compatible with a low-cost meter.

Indexed as

COVID-19SARS-CoV-2Dielectric SpectroscopyElectrodesHumansRNA, ViralSensitivity and SpecificitySpike Glycoprotein, CoronavirusRNA, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID35043638
PMCPMC8790822
OpenAlexW4206505632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.